Bone Morphogenetic Protein Market size is expected to grow at a CAGR of 2.90% during the forecast period and the market size is expected to reach nearly US$ 745.80 Million by 2029. The global Bone Morphogenetic Protein market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Bone Morphogenetic Protein report also provides trends by market segments, technology, and investment with a competitive landscape.To know about the Research Methodology :- Request Free Sample Report
Bone Morphogenetic Protein Market Overview:
BMPs (bone morphogenetic proteins) are a group of naturally occurring proteins that play a role in tissue formation and growth. BMPs are active in tissues other than bone, despite their name. BMP promotes the creation of new bone in the body. The majority of bone morphogenetic proteins (BMPs) are members of the Transforming Growth Factor (TGF) family of proteins. BMPs play a significant role in the development of bone and cartilage, as well as embryogenesis. The most advanced commercial clinical application of BMP has been in spinal fusion surgery products for both lumbar and cervical spine indications. Covid-19 impact on Bone Morphogenetic Protein Market: The global effects of the coronavirus disease 2019 (COVID-19) are already being felt, and the demand for Bone Morphogenetic Protein (BMP) 2 will be significantly impacted in 2020. COVID-19 has the potential to have three major effects on the global economy: directly influencing production and demand, causing supply chain and consumer instability, and having a financial impact on businesses and financial markets.Bone Morphogenetic Protein Market Dynamics:
The importance of bone morphogenetic proteins in medical procedures has improved market prospects. rhBMP-2 and rhBMP-7, two main bone morphogenetic proteins, have recently gained notoriety. The FDA's approvals have considerably contributed to the popularity of bone morphogenetic proteins. Both metabologens and cytokines are bone morphogenetic proteins, and medical research on the former is gaining momentum. The existence of bone morphogenetic proteins influences the body's tissue architecture. This, together with advances in osteopathy, has fueled the market growth. Physiology has attracted the attention of several research schools and scientists. In the global market, the role of bone morphogenetic proteins in physiological research has become a significant demand factor. In the medical community, pathological processes have gained a lot of momentum, which is important for business expansion. The misregulation of bone morphogenetic proteins (BMPs) can be fatal to those who are affected. The global demand for bone morphogenetic proteins has increased significantly as a result of this factor. Biocompatibility risks, rising prices, and the availability of alternative products namely bone grafts, scaffolds, and others may all hinder the global bone morphogenetic protein market's development.Bone Morphogenetic Protein Market Segment Analysis:
Based on Type, the rhBMP-2 protein sub-segment is expected to hold the largest global bone morphogenetic proteins market share. It may happen as a result of the high rate of doctors and surgeons adopting and using the rhBMP-2 protein as a result of the high number of sports injuries. Based on the Application, the Spinal Fusion segment is expected to hold the largest market size during the forecast period. In spinal fusion surgery, bone morphogenetic protein (BMP) is a protein that facilitates bone formation in the body. BMP is generally known for promoting fusion at a faster rate than traditional bone graft surgery, according to studies. As a result, BMP makes it easier for the surgeon to perform the procedure, resulting in a higher fusion rate and avoiding the risks associated with iliac crest autograft (hip) graft harvest. The surgical time is cut in half and complication rates are lower when the hip graft is avoided, resulting in a quicker and less painful recovery. The use of BMP in spinal fusion surgery is increasing as the number of spinal operations increases and the ease of surgery with BMP improves.Bone Morphogenetic Protein Market Regional Insights:
North America currently holds the majority of the industry and is expected to do so for a few more years. The growth of the market in this area is primarily due to a well-established healthcare system, the rapid adoption of Infuse bone morphogenetic protein, increased demand for bone growth stimulators, and the adoption of novel technologies in the region. The protein molecule rhBMP-2 was approved by the US FDA and has since become one of the most common procedures for bone surgeries in the US. According to the National Spinal Cord Injury Statistical Center, nearly 17,730 cases of spinal cord injuries occur annually in the United States in 2019, indicating that the use of bone morphogenetic proteins in the country have a lot of potentials. The demand for bone morphogenetic proteins are expected to grow in Europe over the forecast period, owing to a rise in the incidence of spinal injuries and the number of orthopedic surgeries. Due to an increase in the number of standalone orthopedic clinics and increased knowledge of innovative products and treatments, Asia Pacific is projected to expand at a rapid pace during the forecast era. The objective of the report is to present a comprehensive analysis of the global Bone Morphogenetic Protein market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global Bone Morphogenetic Protein market dynamics, structure by analyzing the market segments and project the global Bone Morphogenetic Protein market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Bone Morphogenetic Protein market make the report investor’s guide.Bone Morphogenetic Protein Market Key Developments:
In September 2019, Medtronic, an Irish medical device firm, announced that it had secured FDA clearance for pivotal, randomized, and prospective clinical trials for the use of Infuse bone graft. The results of the research would enable bone graft to be used in Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures. TLIF is a form of surgery that uses a posterior approach to connect or fuse spinal bones.Bone Morphogenetic Protein Market Scope:Inquire before buying
Global Bone Morphogenetic Protein Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 610.54 Mn. Forecast Period 2023 to 2029 CAGR: 2.9% Market Size in 2029: US $ 745.80 Mn. Segments Covered: by Application Spinal Fusion Trauma Surgery Reconstruction Surgery Oral Maxillofacial Surgery Others by Type rhBMP-2 rhBMP-7 Others Bone Morphogenetic Protein Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Bone Morphogenetic Protein Market Key Players
1. Medtronic 2. Cellumed Co. Ltd. 3. Stryker 4. Sigma Aldrich Co. 5. ProSpec 6. Ember Therapeutics 7. R&D Systems 8. Thermo Fisher Scientific, Inc. 9. DePuy Synthes 10.Nuvasive, Inc. 11.Orthofix Holdings, Inc. 12.Smith and Nephew, Inc. 13.Wright Medical Group N.V. 14.Other Key Players Frequently Asked Questions: 1. Which region has the largest share in Global Bone Morphogenetic Protein Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Bone Morphogenetic Protein Market? Ans: The Global Market is growing at a CAGR of 2.90% during forecasting period 2023-2029. 3. What is scope of the Global Bone Morphogenetic Protein market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global market? Ans: The important key players in the Global Market are – Medtronic, Cellumed Co. Ltd., Stryker, Sigma Aldrich Co., ProSpec, Ember Therapeutics, R&D Systems, Thermo Fisher Scientific, Inc., DePuy Synthes, Nuvasive, Inc., Orthofix Holdings, Inc., Smith and Nephew, and Inc. 5. What is the study period of this market? Ans: The Global Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Bone Morphogenetic Protein Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Bone Morphogenetic Protein Market 3.4. Geographical Snapshot of the Bone Morphogenetic Protein Market, By Manufacturer share 4. Global Bone Morphogenetic Protein Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Bone Morphogenetic Protein Market 5. Supply Side and Demand Side Indicators 6. Global Bone Morphogenetic Protein Market Analysis and Forecast, 2022-2029 6.1. Global Bone Morphogenetic Protein Market Size & Y-o-Y Growth Analysis. 7. Global Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 7.1.1. rhBMP-2 7.1.2. rhBMP-7 7.1.3. Others 7.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 7.2.1. Spinal Fusion 7.2.2. Trauma Surgery 7.2.3. Reconstruction Surgery 7.2.4. Oral Maxillofacial Surgery 7.2.5. Others 8. Global Bone Morphogenetic Protein Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 9.1.1. rhBMP-2 9.1.2. rhBMP-7 9.1.3. Others 9.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 9.2.1. Spinal Fusion 9.2.2. Trauma Surgery 9.2.3. Reconstruction Surgery 9.2.4. Oral Maxillofacial Surgery 9.2.5. Others 10. North America Bone Morphogenetic Protein Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 12. Canada Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 13. Mexico Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 14. Europe Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 15. Europe Bone Morphogenetic Protein Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 17. France Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 18. Germany Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 19. Italy Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 20. Spain Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21. Sweden Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 22. CIS Countries Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23. Rest of Europe Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 24. Asia Pacific Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 25. Asia Pacific Bone Morphogenetic Protein Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 27. India Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 28. Japan Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 29. South Korea Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 30. Australia Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 31. ASEAN Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 32. Rest of Asia Pacific Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 33. Middle East Africa Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 34. Middle East Africa Bone Morphogenetic Protein Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 36. GCC Countries Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 37. Egypt Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 38. Nigeria Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 39. Rest of ME&A Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 40. South America Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 41. South America Bone Morphogenetic Protein Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 43. Argentina Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 44. Rest of South America Bone Morphogenetic Protein Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Bone Morphogenetic Protein Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Medtronic 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Cellumed Co. Ltd. 45.3.3. Stryker 45.3.4. Sigma Aldrich Co. 45.3.5. ProSpec 45.3.6. Ember Therapeutics 45.3.7. R&D Systems 45.3.8. Thermo Fisher Scientific, Inc. 45.3.9. DePuy Synthes 45.3.10. Nuvasive, Inc. 45.3.11. Orthofix Holdings, Inc. 45.3.12. Smith and Nephew, Inc. 45.3.13. Wright Medical Group N.V. 45.3.14. Other Key Players 46. Primary Key Insights